Tracy Doll, OD, FAAO, shares an overview of her anterior segment symposium presented during the 2023 AAOpt annual meeting.

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

As new treatment options continue to enter the glaucoma space, clinicians can provide the best care to each individual patient.

Private practice eye care providers’ ability to immediately administer antibiotic eye drops or have them overnighted to the patient is a giant step forward for practice and patient.

Aldeyra Therapeutics encounters a significant setback, with its stock value plummeting nearly 70%. The FDA indicates a potential Complete Response Letter (CRL) for reproxalap, a dry eye treatment, despite a scheduled Prescription Drug User Fee Act (PDUFA) date of November 23, 2023.

The first approved GA treatment leaves room for additional therapies.

Karen G. Carrasquillo, OD, PhD, FAAO, FSLS, FBCLA, shares highlights from her 2023 AAOpt presentations on scleral lenses, as well as cultural competency.

Therapies and technologies to treat allergic conjunctivitis are rapidly changing.

Shalu Pal, BSc, OD, FAAO, chats about fitting soft, gas permeable, scleral, and hybrid lenses based on her AAOpt ACE course she presented alongside her ACE course, "Multifocal Fitting Tips for Soft, GP, Scleral and Hybrid Lenses," which she presented alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA.

Catch up on what happened in optometry during the week of October 9-October 13.

Drs Paul Chous and Jeffry Gerson brought a new spin on the diabetes talk they've been presenting the last 18 years at the American Academy of Optometry annual meetings.

At AAOpt, Nate Lighthizer, OD, presents a variety of lectures and workshops on lasers and their use in optometry.

Over a dozen visual tests help clinicians identify patients who might benefit from vision therapy.

Ariel Cerenzie, OD, FAAO, FSLS, shares highlights from the recently released Contact Lens Institute report on contact lens culture.

The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.

Innovations in multifocal contact lenses have expanded options.

Gleb Sukhovolskiy discusses his 2023 AAOpt presentation, "Optometrist’s Guide to MIGS and the Continuing Evolution of Glaucoma Treatment."

A groundbreaking study conducted by the International Agency for the Prevention of Blindness (IAPB) and Kevin Frick, PhD, from Johns Hopkins University reveals that prioritizing better eye health could inject a staggering $50.4 billion annually into the US economy.

Himalayan Cataract Project is celebrating World Sight Day by bringing attention to avoidable blindness globally to help individuals in developing countries retain and regain their sight.